Bilcare Stock Screener | Share Price & Fundamental Analysis
BI
Healthcare Technology
Screen Bilcare share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹76.74
▼
-2.02 (-2.56%)
Market Cap
₹195.15 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
0.42
EPS (TTM)
₹-12.23
Dividend Yield
-
Debt to Equity
1.98
52W High
₹112.45
52W Low
₹52.62
Operating Margin
2.00%
Profit Margin
-12.57%
Revenue (TTM)
₹183.00
EBITDA
₹8.00
Net Income
₹-23.00
Total Assets
₹1,417.00
Total Equity
₹590.00
Bilcare Share Price History - Stock Screener Chart
Screen BI historical share price movements with interactive charts. Analyze price trends and patterns.
Bilcare Company Profile - Fundamental Screener
Screen Bilcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for BI shares.
Sector
Healthcare
Industry
Healthcare Technology
Sub-Sector
Healthcare Technology
Segment
E
ISIN
INE986A01012
Bilcare Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen BI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 1,417 | 1,568 | 1,593 | 1,127 | 1,064 | 1,112 | 3,159 | 3,479 | 3,507 | 3,682 |
| Current Assets | 343 | 411 | 343 | 421 | 337 | 365 | 882 | 933 | 788 | 907 |
| Fixed Assets | 949 | 1,038 | 1,046 | 465 | 494 | 534 | 2,006 | 2,180 | 2,403 | 2,433 |
| Liabilities | ||||||||||
| Total Liabilities | 1,417 | 1,568 | 1,593 | 1,127 | 1,064 | 1,112 | 3,159 | 3,479 | 3,507 | 3,682 |
| Current Liabilities | 488 | 572 | 551 | 563 | 586 | 624 | 1,096 | 1,037 | 2,085 | 2,152 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 590 | 646 | 704 | 161 | 164 | 176 | -6 | 463 | 676 | 772 |
| Share Capital | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 |
| Reserves & Surplus | 446 | 474 | 507 | 52 | 63 | 85 | -93 | 376 | 590 | 689 |
Screen BI income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2024-Jun | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 183 | 192 | 215 | 202 | 206 | 198 | 209 | 198 | 465 | 186 | 200 | 179 | 264 | 251 | 264 |
| Expenses | 175 | 175 | 187 | 197 | 204 | 175 | 208 | 175 | 219 | 170 | 183 | 158 | 241 | 233 | 240 |
| EBITDA | 8 | 17 | 29 | 4 | 2 | 23 | 1 | 23 | 246 | 16 | 17 | 21 | 24 | 19 | 24 |
| Operating Profit % | 2.00% | 6.00% | 4.00% | 0.00% | -1.00% | 10.00% | -4.00% | 10.00% | 6.00% | 7.00% | 4.00% | 10.00% | 6.00% | 6.00% | 6.00% |
| Depreciation | 12 | 12 | 12 | 12 | 11 | 12 | 13 | 12 | 9 | 11 | 11 | 11 | 9 | 9 | 9 |
| Interest | 19 | 19 | 19 | 20 | 24 | 21 | 23 | 21 | 11 | 19 | 20 | 21 | 17 | 16 | 16 |
| Profit Before Tax | -24 | -13 | -2 | -27 | -33 | -10 | -35 | -10 | 225 | -13 | -13 | -10 | -3 | -7 | -2 |
| Tax | 0 | -3 | -7 | -11 | -3 | 5 | -16 | 5 | 147 | 0 | -1 | 3 | 1 | -1 | 1 |
| Net Profit | -23 | -10 | 5 | -16 | -30 | -15 | -20 | -15 | 78 | -13 | -12 | -14 | -4 | -6 | -3 |
| EPS | -5.25 | -1.61 | 4.48 | -3.05 | -6.81 | -2.71 | -4.63 | -2.71 | 19.63 | -3.36 | -3.22 | -2.91 | -2.48 | -2.84 | -2.42 |
Bilcare Cash Flow Screener - Liquidity Fundamentals
Screen BI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 63 | -7 | 41 | 72 | 256 | 206 | 99 | 300 | 177 | -315 |
| Investing Activities | -106 | 36 | -4 | 2 | 1,309 | -104 | -203 | -129 | -358 | 247 |
| Financing Activities | 36 | -19 | -55 | -83 | -1,600 | -103 | 91 | -155 | 149 | 119 |
| Net Cash Flow | -8 | 10 | -18 | -9 | -35 | -1 | -13 | 16 | -32 | 50 |
Screen BI shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 30.01% | 30.01% | 30.01% | 30.01% | 30.01% | 30.01% | 30.01% | 30.01% |
| FII Holding | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 45.40% | 44.96% | 44.68% | 45.40% | 45.51% | 45.57% | 45.48% | 45.91% |
| Other Holding | 24.54% | 24.99% | 25.26% | 24.55% | 24.43% | 24.37% | 24.46% | 24.08% |
| Shareholder Count | 16,513 | 17,047 | 17,586 | 18,496 | 18,241 | 18,783 | 19,116 | 19,181 |
Bilcare Dividend Screener - Share Yield Analysis
Screen BI dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Bilcare Index Membership - Market Screener Classification
Screen BI by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Bilcare Market Events Screener - Corporate Actions
Screen BI market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 31.15% | ||
| Annual General Meeting | NA | -7.47% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -5.12% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -1.45% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -0.20% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -13.94% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -5.03% |
Bilcare Competitors Screener - Peer Comparison
Screen BI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Syngene International | 26,530 | 56.67 | 3,714 | 3.77% | 496 | 57.83 |
| Indegene | 12,874 | 28.98 | 2,947 | 10.53% | 407 | 57.72 |
| Suven Life Sciences | 3,906 | -18.47 | 18 | -46.34% | -161 | 45.65 |
| Vimta Labs | 2,795 | 44.95 | 322 | 0.22% | 41 | 51.30 |
| Take Solutions | 565 | 11.39 | 10 | 126.67% | 1 | 93.33 |
| Bilcare | 195 | -4.34 | 807 | 4.78% | -56 | 48.89 |
| Jeevan Scientific Technology | 95 | -21.77 | 48 | 17.87% | 0 | 50.59 |
| Adeshwar Meditex | 26 | 33.09 | 84 | 5.00% | 2 | 21.98 |
| Vanta Bioscience | 15 | -1.11 | 2 | -78.57% | -13 | 41.94 |
Bilcare Company Announcements - News Screener
Screen BI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-14 | Unaudited Financials Result (Standalone And Consolidated) For The Quarter And Half Year Ended 30.09.2025 Along With Limited Review Report. | View |
| 2025-11-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th November 2025 | View |
| 2025-11-06 | Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results For The Quarter And Half Year Ended September 30 2025. | View |
| 2025-10-20 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-10-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-30 | Closure of Trading Window | View |
| 2025-09-25 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-25 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-24 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-16 | Intimation Regarding Change In Website Of The Compnay | View |
| 2025-09-04 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-09-03 | Newspaper Publication Regarding Notice Of 38Th Annual General Meeting | View |
| 2025-09-02 | Notice Of The 38Th Annual General Meeting And The Annual Report For The Financial Year 2024-25 | View |
| 2025-09-02 | Intimation Of Book Closure Dates For 38Th Annual General Meeting Of The Company | View |
| 2025-09-02 | Reg. 34 (1) Annual Report. | View |
| 2025-08-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-14 | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | View |
| 2025-08-14 | Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors | View |
| 2025-08-14 | Unaudited Financials Results (Standalone And Consolidated) For The Quarter Ended 30Th June 2025 Together With The Limited Review Report Of The Statutory Auditors Thereon. | View |